dual 5-HT2C/5-HT6 receptor antagonists (Korea Research Institute of Chemical Technology)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual 5-HT2C/5-HT6 receptor antagonists (Korea Research Institute of Chemical Technology)
Drug Alias Namedual 5-HT2C/5-HT6 receptor antagonists (KRICT)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonistsSerotonin 2c (5-HT2c) receptor antagonists
TargetsSerotonin 2c (5-HT2c) receptorSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsCognition Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCognition Disorders

Other Information

ATC CodeN/A
Related LinksN/A